163 related articles for article (PubMed ID: 26213908)
21. Cleistochlamys kirkii chemical constituents: Antibacterial activity and synergistic effects against resistant Staphylococcus aureus strains.
Pereira F; Madureira AM; Sancha S; Mulhovo S; Luo X; Duarte A; Ferreira MJ
J Ethnopharmacol; 2016 Feb; 178():180-7. PubMed ID: 26674158
[TBL] [Abstract][Full Text] [Related]
22. Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vitro pharmacodynamic models.
LaPlante KL; Leonard SN; Andes DR; Craig WA; Rybak MJ
Antimicrob Agents Chemother; 2008 Jun; 52(6):2156-62. PubMed ID: 18411321
[TBL] [Abstract][Full Text] [Related]
23. Prevalence of resistance phenotypes in Staphylococcus aureus and coagulase-negative isolates of venous ulcers of primary healthcare patients.
Martins MA; Santos Sde L; Leão LS; Araújo NP; Bachion MM
Rev Soc Bras Med Trop; 2012 Dec; 45(6):717-22. PubMed ID: 23295875
[TBL] [Abstract][Full Text] [Related]
24. Growing Resistance to Vancomycin among Methicillin Resistant Staphylococcus Aureus Isolates from Different Clinical Samples.
Pahadi PC; Shrestha UT; Adhikari N; Shah PK; Amatya R
JNMA J Nepal Med Assoc; 2014; 52(196):977-81. PubMed ID: 26982895
[TBL] [Abstract][Full Text] [Related]
25. Methicillin- and Vancomycin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci Isolated from Hospital Foods: Prevalence and Antimicrobial Resistance Patterns.
Afshari A; Taheri S; Hashemi M; Norouzy A; Nematy M; Mohamadi S
Curr Microbiol; 2022 Sep; 79(11):326. PubMed ID: 36125553
[TBL] [Abstract][Full Text] [Related]
26. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (2005)].
Goto H; Takeda H; Kawai S; Watanabe S; Okazaki M; Shimada K; Nakano K; Yokouchi H; Mori T; Igari J; Oguri T; Yamamoto M; Kudo K; Kobayashi N; Tanaka T; Yoshimura K; Kawabata M; Nakamori Y; Sumitomo M; Inoue H; Nakadate T; Suwabe A; Ashino Y; Aoki N; Honma Y; Suzuki Y; Karasawa Y; Oka M; Kobashi Y; Kohno S; Hirakata Y; Kondou A; Matsuda J; Nakano M; Oikawa S
Jpn J Antibiot; 2008 Aug; 61(4):209-40. PubMed ID: 19024644
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of dalbavancin alone and in combination with β-lactam antibiotics against resistant phenotypes of Staphylococcus aureus.
Xhemali X; Smith JR; Kebriaei R; Rice SA; Stamper KC; Compton M; Singh NB; Jahanbakhsh S; Rybak MJ
J Antimicrob Chemother; 2019 Jan; 74(1):82-86. PubMed ID: 30260409
[TBL] [Abstract][Full Text] [Related]
28. Synergistic effect of non-steroidal anti-inflammatory drugs (NSAIDs) on antibacterial activity of cefuroxime and chloramphenicol against methicillin-resistant Staphylococcus aureus.
Chan EWL; Yee ZY; Raja I; Yap JKY
J Glob Antimicrob Resist; 2017 Sep; 10():70-74. PubMed ID: 28673701
[TBL] [Abstract][Full Text] [Related]
29. [Resistance of Staphylococcus aureus isolated from burn wounds to antibiotics].
Grigaite R; Pavilonis A; Rimdeika R; Antusevas A
Medicina (Kaunas); 2006; 42(5):377-83. PubMed ID: 16778465
[TBL] [Abstract][Full Text] [Related]
30. A report on infection dynamics of inducible clindamycin resistance of Staphylococcus aureus isolated from a teaching hospital in India.
Dubey D; Rath S; Sahu MC; Rout S; Debata NK; Padhy RN
Asian Pac J Trop Biomed; 2013 Feb; 3(2):148-53. PubMed ID: 23593595
[TBL] [Abstract][Full Text] [Related]
31. [The prevalence of antiseptic resistance genes (qacA/B and smr) and antibiotic resistance in clinical Staphylococcus aureus strains].
Nakipoğlu Y; Iğnak S; Gürler N; Gürler B
Mikrobiyol Bul; 2012 Apr; 46(2):180-9. PubMed ID: 22639307
[TBL] [Abstract][Full Text] [Related]
32. Detection and prevalence of inducible clindamycin resistance in staphylococci.
Yilmaz G; Aydin K; Iskender S; Caylan R; Koksal I
J Med Microbiol; 2007 Mar; 56(Pt 3):342-345. PubMed ID: 17314364
[TBL] [Abstract][Full Text] [Related]
33. Synergy between vancomycin and nafcillin against Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
Leonard SN
PLoS One; 2012; 7(7):e42103. PubMed ID: 22848719
[TBL] [Abstract][Full Text] [Related]
34. Antimicrobial susceptibility pattern of clinical isolates of methicillin resistant Staphylococcus aureus.
Perwaiz S; Barakzi Q; Farooqi BJ; Khursheed N; Sabir N
J Pak Med Assoc; 2007 Jan; 57(1):2-4. PubMed ID: 17319409
[TBL] [Abstract][Full Text] [Related]
35. Antistaphylococcal activity of dihydrophthalazine antifolates, a family of novel antibacterial drugs.
Clark C; Ednie LM; Lin G; Smith K; Kosowska-Shick K; McGhee P; Dewasse B; Beachel L; Caspers P; Gaucher B; Mert G; Shapiro S; Appelbaum PC
Antimicrob Agents Chemother; 2009 Apr; 53(4):1353-61. PubMed ID: 19188385
[TBL] [Abstract][Full Text] [Related]
36. Macrolide-lincosamide-streptogramin B resistance phenotypes and genotypes among Staphylococcus aureus clinical isolates in Japan.
Otsuka T; Zaraket H; Takano T; Saito K; Dohmae S; Higuchi W; Yamamoto T
Clin Microbiol Infect; 2007 Mar; 13(3):325-7. PubMed ID: 17391391
[TBL] [Abstract][Full Text] [Related]
37. Macrolide-lincosamide-streptogramin B resistance phenotypes and their associated genotypes in Staphylococcus aureus isolates from a tertiary level public hospital of Uruguay.
Pardo L; Machado V; Cuello D; Aguerrebere P; Seija V; Braga V; Varela G
Rev Argent Microbiol; 2020; 52(3):202-210. PubMed ID: 31928835
[TBL] [Abstract][Full Text] [Related]
38. [Investigation of macrolide-lincosamide-streptogramin B (MLS(B)) and telithromycin resistance in clinical strains of staphylococci].
Saribaş Z; Tunçkanat F; Ozçakir O; Ercis S
Mikrobiyol Bul; 2010 Apr; 44(2):177-86. PubMed ID: 20549951
[TBL] [Abstract][Full Text] [Related]
39. Susceptibility of Staphylococcus aureus clinical isolates to propolis extract alone or in combination with antimicrobial drugs.
Wojtyczka RD; Dziedzic A; Idzik D; Kępa M; Kubina R; Kabała-Dzik A; Smoleń-Dzirba J; Stojko J; Sajewicz M; Wąsik TJ
Molecules; 2013 Aug; 18(8):9623-40. PubMed ID: 23941882
[TBL] [Abstract][Full Text] [Related]
40. Antistaphylococcal activities of CG400549, a new bacterial enoyl-acyl carrier protein reductase (FabI) inhibitor.
Park HS; Yoon YM; Jung SJ; Kim CM; Kim JM; Kwak JH
J Antimicrob Chemother; 2007 Sep; 60(3):568-74. PubMed ID: 17606482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
